These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 22248785)

  • 1. A two year observation of the process of applying recombinant IGF-1 to treat short stature in children with primary IGF-1 deficiency -- case reports of 3 patients.
    Petriczko E; Wikiera B; Horodnicka-Józwa A; Marcinkiewicz K; Szmit-Domagalska J; Kędzia A; Durzyńska J; Broniarczyk J; Gabryelczyk B; Noczyńska A; Walczak M
    Pediatr Endocrinol Diabetes Metab; 2011; 17(4):233-8. PubMed ID: 22248785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant human insulin-like growth factor-I therapy for children with growth disorders.
    Richmond EJ; Rogol AD
    Adv Ther; 2008 Dec; 25(12):1276-87. PubMed ID: 19066756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of severe primary IGF-1 deficiency using rhIGF-1 preparation - first three years of Polish experience.
    Petriczko E; Jackowski T; Horodnicka-Józwa A; Wikiera B; Noczyńska A; Korpal-Szczyrska M; Birkholz-Walerzak D; Małecka-Tendera E; Kalina-Fraska B; Kalina M; Barg E; Beń-Skowronek I; Szewczyk L; Hilczer M; Smyczyńska J; Stawerska R; Lewiński A; Ziora K; Bossowski A; Pietrewicz E; Pyrżak B; Kędzia A; Szalecki M; Kilian A; Walczak M
    Endokrynol Pol; 2019; 70(1):20-27. PubMed ID: 30351442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of recombinant human insulin-like growth factor-I in treating children with short stature.
    Collett-Solberg PF; Misra M;
    J Clin Endocrinol Metab; 2008 Jan; 93(1):10-8. PubMed ID: 18165284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mecasermin: new drug. Insufficient improvement in statural growth.
    Prescrire Int; 2009 Jun; 18(101):111-3. PubMed ID: 19637420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-like growth factor-I deficiency in children with growth hormone insensitivity: current and future treatment options.
    Kemp SF
    BioDrugs; 2009; 23(3):155-63. PubMed ID: 19627167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant insulin-like growth factor (IGF)-I treatment in short children with low IGF-I levels: first-year results from a randomized clinical trial.
    Midyett LK; Rogol AD; Van Meter QL; Frane J; Bright GM;
    J Clin Endocrinol Metab; 2010 Feb; 95(2):611-9. PubMed ID: 19880790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mecasermin (recombinant human insulin-like growth factor I).
    Rosenbloom AL
    Adv Ther; 2009 Jan; 26(1):40-54. PubMed ID: 19198769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant human insulin-like growth factor I (IGF-I): risks and benefits of normalizing blood IGF-I concentrations.
    Clark RG
    Horm Res; 2004; 62 Suppl 1():93-100. PubMed ID: 15761240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant human insulin-like growth factor-1 treatment: ready for primetime.
    Bright GM; Mendoza JR; Rosenfeld RG
    Endocrinol Metab Clin North Am; 2009 Sep; 38(3):625-38. PubMed ID: 19717008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term treatment with recombinant insulin-like growth factor (IGF)-I in children with severe IGF-I deficiency due to growth hormone insensitivity.
    Chernausek SD; Backeljauw PF; Frane J; Kuntze J; Underwood LE;
    J Clin Endocrinol Metab; 2007 Mar; 92(3):902-10. PubMed ID: 17192294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of recombinant insulin-like growth factor I in the treatment of the short child.
    Rosenbloom AL
    Curr Opin Pediatr; 2007 Aug; 19(4):458-64. PubMed ID: 17630612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant human insulin-like growth factor I (rhIGF-I) and rhIGF-I/rhIGF-binding-protein-3: new growth treatment options?
    Rosenbloom AL
    J Pediatr; 2007 Jan; 150(1):7-11. PubMed ID: 17188604
    [No Abstract]   [Full Text] [Related]  

  • 14. Anaphylactic reaction to recombinant insulin-like growth factor-I.
    Torjusen E; Calderon J; Rivkees SA
    J Pediatr Endocrinol Metab; 2008 Apr; 21(4):381-4. PubMed ID: 18556970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth hormone-resistant syndromes: long-term follow-up.
    Chernausek SD
    Endocr Dev; 2009; 14():135-42. PubMed ID: 19293580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statement 5: the first line of treatment for children with idiopathic short stature (ISS) and low serum insulin-like growth factor-I (IGF-I) should be IGF-I.
    Backeljauw P
    Pediatr Endocrinol Rev; 2008 Apr; 5 Suppl 3():853-6. PubMed ID: 18438329
    [No Abstract]   [Full Text] [Related]  

  • 17. Recombinant Human Insulin-Like Growth Factor-1 Treatment of Severe Growth Failure in Three Siblings with STAT5B Deficiency.
    Muthuvel G; Al Remeithi SS; Foley C; Dauber A; Hwa V; Backeljauw P
    Horm Res Paediatr; 2024; 97(2):195-202. PubMed ID: 37586336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant insulin-like growth factor-1 as a therapy for IGF-1 deficiency in renal failure.
    Clark RG
    Pediatr Nephrol; 2005 Mar; 20(3):290-4. PubMed ID: 15682316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment perspectives in idiopathic short stature with a focus on IGF-I deficiency.
    Rosenthal S; Cohen P; Clayton P; Backeljauw P; Bang P; Ten S
    Pediatr Endocrinol Rev; 2007 May; 4 Suppl 2():252-71. PubMed ID: 17581497
    [No Abstract]   [Full Text] [Related]  

  • 20. Recombinant human IGF-1 (insulin-like growth factor) therapy: where do we stand today?
    Balhara B; Misra M; Levitsky LL
    Indian J Pediatr; 2012 Feb; 79(2):244-9. PubMed ID: 22090255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.